MERCK KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149 EUR | -0.67% |
|
+0.85% | +3.37% |
| 10:28am | MERCK KGAA : Jefferies keeps its Buy rating | ZD |
| Apr. 29 | Habeck's 'pharma trip' - industry sees structural problems | DP |
Chart calendar Merck KGaA
4e72a35d19d9424b9fd8d650.N4p2baEHureCIlQxNme1jKBpiaq_oiLJ00ws0vUG96U.RsE8INQz8NPYQwx0bgvs--MF-MT78RWIgwR-mZ93uO92xx8O6jD96LRsZA~cef00f78737547dc26694180173b6c1f
Upcoming events on Merck KGaA
Past events on Merck KGaA
| 2024-04-28 | Ex-dividend day for final dividend |
| 2024-04-26 04:00 am | Annual General Meeting |
| 2024-03-07 08:00 am | Q4 2023 Earnings Call |
| 2024-03-07 01:00 am | Q4 2023 Earnings Release |
| 2024-01-08 12:00 pm | JPMorgan Healthcare Conference |
| 2023-11-14 | Jefferies London Healthcare Conference |
| 2023-11-09 07:00 am | Q3 2023 Earnings Call |
| 2023-11-09 12:00 am | Q3 2023 Earnings Release |
| 2023-11-06 | Societe Generale European ESG Conference |
| 2023-10-19 04:00 am | Capital Markets Day |
| 2023-08-28 | Display Innovation China EXPO & Forum |
| 2023-08-03 08:00 am | Q2 2023 Earnings Call |
| 2023-08-02 | Q2 2023 Earnings Release |
| 2023-05-11 08:00 am | Q1 2023 Earnings Call |
| 2023-05-11 01:00 am | Q1 2023 Earnings Release |
| 2023-05-01 | Ex-dividend day for final dividend |
| 2023-04-28 04:00 am | Annual General Meeting |
| 2023-03-02 08:00 am | Q4 2022 Earnings Call |
| 2023-03-02 01:00 am | Q4 2022 Earnings Release |
| 2023-01-11 02:15 pm | JP Morgan Healthcare Conference |
Past dividends on Merck KGaA
| 2024-04-28 | Annual 2.2 EUR |
| 2023-05-01 | Annual 2.2 EUR |
| 2022-04-24 | Annual 1.85 EUR |
| 2021-04-25 | Annual 1.4 EUR |
| 2020-05-28 | Annual 1.3 EUR |
| 2019-04-28 | Annual 1.25 EUR |
| 2018-04-29 | Annual 1.25 EUR |
| 2017-05-01 | Annual 1.2 EUR |
| 2016-05-01 | Annual 1.05 EUR |
| 2015-04-19 | Annual 1 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 16 152 16 092 0.37% | 17 534 17 407 0.73% | 19 687 19 632 0.28% | 22 232 22 259 -0.12% | 20 993 21 026 -0.16% | 21 244 |
|
EBITDA Million EUR | Released Forecast Spread | 4 385 4 335 1.15% | 5 201 5 081 2.36% | 6 103 6 096 0.12% | 6 849 6 898 -0.71% | 5 879 5 823 0.97% | 5 843 |
|
EBIT Million EUR | Released Forecast Spread | 2 120 2 262 -6.29% | 2 985 2 985 -0.01% | 4 179 4 150 0.69% | 4 474 4 933 -9.29% | 3 609 3 730 -3.24% | 3 883 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 735 1 928 -9.99% | 2 630 2 726 -3.52% | 3 924 3 886 0.97% | 4 287 4 727 -9.3% | 3 484 3 695 -5.72% | 3 798 |
|
Net income Million EUR | Released Forecast Spread | 1 320 1 448 -8.85% | 1 987 1 999 -0.57% | 3 055 2 986 2.3% | 3 326 3 674 -9.48% | 2 824 2 831 -0.26% | 2 970 |
|
EPS EUR | Released Forecast Spread | 3,04 3,36 -9.47% | 4,57 4,62 -1.11% | 7,03 6,89 2.1% | 7,65 8,46 -9.54% | 6,49 6,50 -0.22% | 6,82 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 8 489 8 553 -0.75% | 5 213 5 172 0.8% | 5 198 5 218 -0.38% | 5 568 5 417 2.79% | 5 806 5 695 1.95% | 5 660 5 698 -0.66% | 5 293 5 254 0.73% | 5 302 5 221 1.55% | 5 173 5 255 -1.56% | 5 225 5 248 -0.44% | 5 174 | 5 248 | 5 338 | 5 463 |
|
EBITDA Million EUR | Released Forecast Spread | 2 256 2 232 1.06% | 1 464 1 452 0.82% | 1 629 1 631 -0.15% | 1 782 1 709 4.27% | 1 811 1 795 0.85% | 1 628 1 658 -1.83% | 1 587 1 550 2.41% | 1 553 1 511 2.76% | 1 446 1 369 5.66% | 1 293 1 256 2.95% | 1 327 | 1 408 | 1 485 | 1 693 |
|
EBIT Million EUR | Released Forecast Spread | 1 039 1 138 -8.7% | 1 173 1 198 -2.07% | 1 177 1 248 -5.66% | 1 234 1 319 -6.45% | 890 1 241 -28.29% | 1 035 1 124 -7.95% | 969 1 028 -5.7% | 983 903 8.89% | 621 750 -17.18% | 725 | 807 | 1 068 | 1 129 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 992 1 083 -8.44% | 1 139 1 131 0.74% | 1 122 1 207 -7.05% | 1 187 1 266 -6.26% | 839 1 202 -30.19% | 1 012 1 088 -7.01% | 894 981 -8.88% | 937 850 10.29% | 641 839 -23.56% | 703 | 782 | 1 043 | 1 097 | |
|
Net income Million EUR | Released Forecast Spread | 802 812 -1.23% | 880 880 0.02% | 867 931 -6.86% | 923 980 -5.76% | 655 967 -32.26% | 796 825 -3.53% | 704 765 -8% | 739 658 12.37% | 586 647 -9.4% | 650 | 704 | 840 | 850 | |
|
EPS EUR | Released Forecast Spread | 1,72 1,86 -7.53% | 1,84 1,84 0.26% | 2,02 2,02 -0.16% | 1,99 2,13 -6.65% | 2,12 2,27 -6.43% | 1,51 2,22 -32.06% | 1,83 1,90 -3.6% | 1,62 1,76 -8.06% | 1,70 1,54 10.21% | 1,34 1,50 -10.42% | 1,51 | 1,62 | 1,93 | 1,97 |
| Announcement Date | 06/08/20 | 03/03/22 | 12/05/22 | 04/08/22 | 10/11/22 | 02/03/23 | 11/05/23 | 03/08/23 | 09/11/23 | 07/03/24 | - | - | - | - |
| 2024-05-05 | HK INNO.N CORPORATION: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
| 2024-05-06 | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | OSCOTEC INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-12 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-12 | YUHAN CORPORATION: Q1 2024 Earnings Release (Projected) |
| 2024-05-15 01:00 am | MERCK KGAA: Q1 2024 Earnings Release |
Past sector events for Merck KGaA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Calendar Merck KGaA
